{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 2085"}, "official-title": {"#tail": "\n\t", "#text": "To create incentive for innovative diagnostics by\n\t\t  improving the process for determining Medicare payment rates for new\n\t\t  tests."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130522", "#text": "May 22, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in addition to the Committee on\n\t\t\t ", "@committee-id": "HIF00", "#text": "Committee on Energy and\n\t\t\t Commerce"}, {"#tail": ", for a\n\t\t\t period to be subsequently determined by the Speaker, in each case for\n\t\t\t consideration of such provisions as fall within the jurisdiction of the\n\t\t\t committee concerned", "@committee-id": "HWM00", "#text": "Ways and Means"}], "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. Roskam", "@name-id": "R000580"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Mr. Neal", "@name-id": "N000015"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Lance", "@name-id": "L000567"}, {"#tail": ", ", "#text": "Mr. Kind", "@name-id": "K000188"}, {"#tail": ", ", "#text": "Mr. Guthrie", "@name-id": "G000558"}, {"#tail": ", and ", "#text": "Mr.\n\t\t\t Paulsen", "@name-id": "P000594"}, {"#tail": ")\n\t\t\t introduced the following bill; which was referred to the\n\t\t\t ", "#text": "Mr. Tiberi", "@name-id": "T000462"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H8B8E35A8353D4BA8975FFE8615F57707", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Diagnostic Innovation Testing and\n\t\t\t Knowledge Advancement Act of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H31DA95BE0C4948FD8E9A71449C42583F"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Creating\n\t\t\t incentives for innovative diagnostics"}, "subsection": [{"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Improvements To\n\t\t\t process for determining fee schedule amounts for new tests"}, "paragraph": [{"#tail": "\n        ", "@id": "H7E4E96364E7C48289B9C55BA19B80B18", "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Clarifying\n\t\t\t factors for rate-setting"}, "text": {"{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (in this section referred to as the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "term": {"#tail": ") shall take into account, as applicable and available,\n\t\t\t the following factors with respect to such a new test:", "#text": "Secretary"}, "#tail": "\n\t\t\t\t\t", "external-xref": {"#tail": " of title 42, Code of Federal Regulations, or any successor\n\t\t\t regulation to such section) for new clinical diagnostic laboratory tests under\n\t\t\t ", "@parsable-cite": "cfr/42/414.508", "#text": "section 414.508(b)", "@legal-doc": "regulation"}, "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", the\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 1833(h)(8) of the Social Security Act", "@value": "Social Security Act/s:1833/ss:h/p:8"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395l(h)(8)", "@value": "usc/42/1395l/h/8"}, "@parsable-cite": "usc/42/1395l", "#text": "\n                ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline", "#text": "In\n\t\t\t determining the payment amount under gapfilling procedures (as described in\n\t\t\t "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "The impact of\n\t\t\t the new test on patient care, patient management, or patient treatment.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "header": {"#tail": "\n            ", "#text": "Impact on\n\t\t\t patient care"}, "#text": "\n            ", "@id": "H9449F27CBA7F4BA78864CF75D245EC71", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "The technical\n\t\t\t characteristics of the new test, and the resources required to develop,\n\t\t\t validate, and perform the new test.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "header": {"#tail": "\n            ", "#text": "Technical\n\t\t\t characteristics"}, "#text": "\n            ", "@id": "H69B4238F10674F6D8656AEE5E853DEE4", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "part B of title XVIII of the Social Security\n\t\t\t Act", "@value": "Social Security Act/t:XVIII/pt:B"}, "#text": "Data from claims for\n\t\t\t which payment is made under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "header": {"#tail": "\n            ", "#text": "Claims\n\t\t\t data"}, "#text": "\n            ", "@id": "H6F93FD7B4450441F89151D431966234F", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "Amounts charged by\n\t\t\t laboratories to self-pay patients for the new test.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "header": {"#tail": "\n            ", "#text": "Laboratory\n\t\t\t charges"}, "#text": "\n            ", "@id": "H3ECD06B7089D49868348E62820EEAF80", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "Amounts paid\n\t\t\t to laboratories for such new test under private health insurance coverage\n\t\t\t offered in the group market and the individual market.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(E)"}, "header": {"#tail": "\n            ", "#text": "Private\n\t\t\t insurance rates"}, "#text": "\n            ", "@id": "HCFC92E92611948698F709B09181AFF78", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to that new test and any comments received during the open\n\t\t\t meeting of the advisory panel.", "@entity-type": "act", "#text": "paragraph\n\t\t\t (2)", "@value": "Diagnostic Innovation Testing and Knowledge Advancement Act of 2013/s:2/ss:a/p:2", "@proposed": "true"}, "#text": "The findings\n\t\t\t and recommendations of the independent advisory panel convened under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(F)"}, "header": {"#tail": "\n            ", "#text": "Advisory panel\n\t\t\t recommendations"}, "#text": "\n            ", "@id": "H802C457BF9184EEB8AE6FA2B4196AAF7", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may specify.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Such other factors as\n\t\t\t the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(G)"}, "header": {"#tail": "\n            ", "#text": "Additional\n\t\t\t factors"}, "#text": "\n            ", "@id": "HD5CB526B05234C53939A72FF29A5201B", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n        ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall convene an independent\n\t\t\t advisory panel from which the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall request information and\n\t\t\t recommendations regarding any new test (as referred to under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t of ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Social Security Act/s:1833/ss:h/p:8/sp:A"}], "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") for\n\t\t\t which payment is made under such section, including technical, clinical, and\n\t\t\t quality information.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 1833(h)(8) of the Social Security Act", "@value": "Social Security Act/s:1833/ss:h/p:8"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395l(h)(8)", "@value": "usc/42/1395l/h/8"}, "@parsable-cite": "usc/42/1395l", "#text": "\n                  ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "header": {"#tail": "\n            ", "#text": "Requirement for\n\t\t\t independent advisory panel"}, "#text": "\n            ", "@id": "H7302828147664231A7D660D352D5AFE9", "@commented": "no"}, {"#tail": "\n          ", "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "7 individuals with expertise and experience\n\t\t\t with clinical diagnostic laboratory tests including expertise in the technical\n\t\t\t characteristics of the new test as well as expertise in the requirements to\n\t\t\t develop, validate, and perform the new test;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "#text": "\n              ", "@id": "HB98BC8842C3A43F1808E0E217AF7FED2", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "3 representatives\n\t\t\t of patients, including a patient representative for rare disorders;"}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "#text": "\n              ", "@id": "H59AF1AE16BFB4EB3AF9C1AA5FEB83F52", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "3 clinicians who\n\t\t\t use results of the new test in patient care;"}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "#text": "\n              ", "@id": "HAEFCEB13BE814318A481D9BA02A01F56", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "2\n\t\t\t laboratorians;"}, "enum": {"#tail": "\n              ", "#text": "(iv)"}, "#text": "\n              ", "@id": "H6276A868169B4E3D871C6C0F62F974BE", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "2 individuals with\n\t\t\t expertise in the area of pharmacoeconomics or health technology assessment;\n\t\t\t and"}, "enum": {"#tail": "\n              ", "#text": "(v)"}, "#text": "\n              ", "@id": "HC0040700AEC94DB5A2734331DFBA4A9A", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "2 individuals\n\t\t\t with expertise on the impact of new tests on quality of patient care, including\n\t\t\t genetic counselors."}, "enum": {"#tail": "\n              ", "#text": "(vi)"}, "#text": "\n              ", "@id": "H356687AD1B9D42949FD861EECF93AEF4", "@commented": "no"}], "enum": {"#tail": "\n            ", "#text": "(B)"}, "header": {"#tail": "\n            ", "#text": "Composition of\n\t\t\t independent advisory panel"}, "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the\n\t\t\t independent advisory panel shall be comprised of 19 members, including\u2014", "@entity-type": "act", "#text": "subparagraph (D)", "@value": "Diagnostic Innovation Testing and Knowledge Advancement Act of 2013/s:2/ss:a/p:2/sp:D", "@proposed": "true"}, "#text": "Subject to ", "@display-inline": "yes-display-inline"}, "#text": "\n            ", "@id": "H6E7CE64630F24F0E8432B46E9DAF00AB", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a member of\n\t\t\t the panel shall be appointed to serve a term of 6 years, except with respect to\n\t\t\t the members first appointed, whose terms of appointment shall be staggered\n\t\t\t evenly over 2-year increments.", "@entity-type": "act", "#text": "subparagraph (D)", "@value": "Diagnostic Innovation Testing and Knowledge Advancement Act of 2013/s:2/ss:a/p:2/sp:D", "@proposed": "true"}, "#text": "Subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "header": {"#tail": "\n            ", "#text": "Terms"}, "#text": "\n            ", "@id": "HBF651870CB2741A7ADA02642E7361004", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " determines with\n\t\t\t respect to a new test that there are an insufficient number of members of the\n\t\t\t panel with expertise with respect to that specific test, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may\n\t\t\t appoint individuals who have expertise pertaining to the new test involved to\n\t\t\t serve on the panel.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Insofar as the "}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "header": {"#tail": "\n            ", "#text": "Temporary\n\t\t\t appointment of experts"}, "#text": "\n            ", "@id": "HFDC68E2F28E34567B48591490C876D45"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t receive or review the findings and recommendations of the independent advisory\n\t\t\t panel with respect to the new tests described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " involved\n\t\t\t during a meeting open to the public and provide opportunity for public\n\t\t\t comment.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Diagnostic Innovation Testing and Knowledge Advancement Act of 2013/s:2/ss:a/p:2/sp:A", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(E)"}, "header": {"#tail": "\n            ", "#text": "Open\n\t\t\t meetings"}, "#text": "\n            ", "@id": "HCD7CDC8D58344A91938987BC66C250AA", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to consult with appropriate\n\t\t\t Medicare administrative contractors.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Nothing in this section shall be construed\n\t\t\t as affecting the authority of the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(F)"}, "header": {"#tail": "\n            ", "#text": "Clarification of\n\t\t\t authority of secretary to consult carriers"}, "#text": "\n            ", "@id": "HDF675EF3447240638D8659A9D3360DBD", "@commented": "no"}], "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Input from\n\t\t\t patients, clinicians, and technical experts"}, "#text": "\n          ", "@id": "H337923CDF1EC489792A59FF34B4D20A2", "@commented": "no"}, {"#tail": "\n      ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall publicly provide a justification for the\n\t\t\t payment basis and payment rate determination, including a detailed summary of\n\t\t\t the information submitted to, or obtained by, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " regarding the\n\t\t\t factors specified in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", such that interested stakeholders can\n\t\t\t readily understand the Secretary\u2019s rationale for the payment basis and rate\n\t\t\t determinations.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Diagnostic Innovation Testing and Knowledge Advancement Act of 2013/s:2/ss:a/p:1", "@proposed": "true"}], "#text": "With respect to decisions regarding payments made\n\t\t\t under the clinical laboratory fee schedule for new clinical diagnostic\n\t\t\t laboratory tests, the "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "header": {"#tail": "\n            ", "#text": "Initial\n\t\t\t justification"}, "#text": "\n            ", "@id": "H031DF1799EFA4675BB319986981C56C7"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall provide for a reasonable period\n\t\t\t of reconsideration to receive any appeal of the determination and to evaluate\n\t\t\t any additional information received regarding the justification and the factors\n\t\t\t specified in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Diagnostic Innovation Testing and Knowledge Advancement Act of 2013/s:2/ss:a/p:1", "@proposed": "true"}], "#text": "After providing such justification for a payment basis and\n\t\t\t payment rate determination, the "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "header": {"#tail": "\n            ", "#text": "Reconsideration\n\t\t\t period"}, "#text": "\n            ", "@id": "HAA397B5EA1DE4DEA8D45A41C6648D2BE"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t shall make a final payment basis and payment rate determination and provide a\n\t\t\t justification for such final determination explaining what additional\n\t\t\t information was evaluated during the reconsideration and how such information\n\t\t\t was taken into account with respect to the final determination. Nothing in this\n\t\t\t paragraph shall be construed as authorizing the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " to reveal proprietary\n\t\t\t information which is otherwise prohibited from disclosure under law.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "After the period of reconsideration the "}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "header": {"#tail": "\n            ", "#text": "Final\n\t\t\t determination"}, "#text": "\n            ", "@id": "HE5DCC1DF985A42A39B5732E4E2870263"}], "enum": {"#tail": "\n          ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Justification\n\t\t\t for payment determinations"}, "#text": "\n          ", "@id": "H03B94231358D4D028835110EE503E60A"}], "#text": "\n        ", "@id": "H11AE3205FF5542659588FE7D5BF04150", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish a process for application for the assignment of a\n\t\t\t temporary national HCPCS code to uniquely identify a diagnostic test until a\n\t\t\t permanent national HCPCS code is available for assignment to that test.\n\t\t\t Assignments of a temporary national HCPCS code shall occur on a quarterly\n\t\t\t basis. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall provide public notice through the Centers for\n\t\t\t Medicare & Medicaid Services Web site of applications made for such\n\t\t\t temporary national HCPCS codes. Upon assignment of a temporary code under this\n\t\t\t process, the Secretary shall treat such test as a new test for purposes of\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "section 1833(h)(8) of the Social Security Act", "@value": "Social Security Act/s:1833/ss:h/p:8"}], "#text": "The\n\t\t\t ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Process for\n\t\t\t assignment of temporary codes for diagnostic tests"}, "#text": "\n        ", "@id": "HF15060821AB5410DA425B4E060D246CC", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall analyze the process\n\t\t\t used for the gapfilling procedure used in determining payment amounts for new\n\t\t\t clinical diagnostic laboratory tests under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". Taking into account the changes made by this section, the\n\t\t\t ", "@entity-type": "act", "#text": "section 1833(h)(8) of the Social\n\t\t\t Security Act", "@value": "Social Security Act/s:1833/ss:h/p:8"}, {"#tail": " shall identify further changes to improve the accuracy and\n\t\t\t appropriateness of resulting rates and the openness, transparency, and\n\t\t\t predictability of the process. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall examine what and how many\n\t\t\t entities should perform gapfilling, under contract or otherwise, and how to\n\t\t\t ensure that the process is informed by appropriate expertise and proceeds in a\n\t\t\t transparent and accountable manner. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall implement improvements\n\t\t\t in the process, insofar as these are possible under the law through\n\t\t\t regulations, after public notice and opportunity for comment. For changes the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " determines would require a change in law, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall\n\t\t\t transmit recommendations to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-parent-id": "0050", "@entity-type": "federal-body", "#text": "Speaker of the House", "@value": "Speaker of the House of Representatives"}, {"#tail": " not later than July 1, 2014.", "@entity-parent-id": "0010", "@entity-type": "federal-body", "#text": "President of the\n\t\t\t Senate", "@value": "President of the Senate"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Development of\n\t\t\t further improvements in rate-Setting processes"}, "#text": "\n        ", "@id": "H2D75D68745DA4203B2E6D0E0270F8D50", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "For purposes of this section:", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n        ", "@id": "H72866D5FA6E7421689704BEBA190AB45", "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "New clinical\n\t\t\t diagnostic laboratory tests"}, "text": {"#tail": "\n\t\t\t\t\t", "term": {"#tail": " means a clinical diagnostic laboratory test\u2014", "#text": "new clinical diagnostic\n\t\t\t laboratory test"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "that is assigned a\n\t\t\t new or substantially revised code on or after January 1, 2013; or"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H34D4ADF6FDDB4154B75C22E629659A75", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " on or after\n\t\t\t January 1, 2014.", "@entity-type": "act", "#text": "subsection (b)", "@value": "Diagnostic Innovation Testing and Knowledge Advancement Act of 2013/s:2/ss:b", "@proposed": "true"}, "#text": "for which a\n\t\t\t temporary national HCPCS code is granted under "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H75B40DA2BBC2475AB730C6DA1C688A6E", "#text": "\n            "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "term": {"#tail": " means, with\n\t\t\t respect to a health care item or service, an individual who pays out of pocket\n\t\t\t for such item or service and who does not have health insurance coverage for\n\t\t\t such item or service.", "#text": "self-pay patient"}, "#text": "The term "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Self-pay\n\t\t\t patient"}, "#text": "\n          ", "@id": "HCE9CEFE03F0044FFAA6775FEAA9FB8AF"}], "#text": "\n        ", "@id": "HAABCA044A21346ECAB04A3BAC27BD3E9"}, {"#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Effective\n\t\t\t date"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", this section shall take effect\n\t\t\t on the date of enactment of this Act and shall apply with respect to new\n\t\t\t clinical diagnostic laboratory tests.", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Diagnostic Innovation Testing and Knowledge Advancement Act of 2013/s:2/ss:e/p:2", "@proposed": "true"}, "#text": "Subject to "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In\n\t\t\t general"}, "#text": "\n          ", "@id": "HED0A8CE31D6C4D2298876803B78703F7"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t shall apply to payment basis and payment rate determinations made on or after\n\t\t\t January 1, 2013.", "@entity-type": "act", "#text": "Subsection (a)(3)", "@value": "Diagnostic Innovation Testing and Knowledge Advancement Act of 2013/s:2/ss:a/p:3", "@proposed": "true"}, "#text": "\n            "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Application of\n\t\t\t justifications to current rate determinations"}, "#text": "\n          ", "@id": "H48F53B4DD0364047A7DA6B0F408673AB"}], "#text": "\n        ", "@id": "H935C7461BDEF4749A27570C9137420BF", "@commented": "no"}], "#text": "\n      ", "@id": "H466E8322873E4F02ADD39DCEB4BE9F5D", "@commented": "no"}], "#text": "\n\t\t", "@id": "HDFAA80B374CE45919696E530C9F52E67"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-05-22"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 2085 IH: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}